A new test to help select colorectal cancer therapy is the first in a menu of rapid cartridge-based tests the firm is planning to support cancer testing.

The test supports rapid diagnosis, treatment monitoring, and treatment guidance for patients with leptomeningeal metastases.

The companies will use Abbott's RT-PCR Simpli-Collect STI Test for detection and differentiation of the causes of sexually transmitted infections.

The test is a bead-based multiplexed immunoassay that also utilizes a machine learning classifier to determine whether a patient has Lyme disease.